Abstract

Disorders of phosphorus metabolism are independent risk factors for progression of chronic kidney disease (CKD). Since dietary phosphorus intake plays a central role in the pathogenesis of disordered phosphorus homeostasis in CKD, these findings have renewed interest in restricting phosphorus intake as a potential therapy for slowing kidney function decline. While the balance of experimental and human data support this possibility, the lack of randomized, controlled trials examining the efficacy of dietary phosphorus restriction in CKD patients precludes the ability to advocate phosphorus restriction for preserving kidney function at this time. Future studies will need to determine whether limiting phosphorus intake is effective for slowing CKD progression and if so, determine the optimal timing of phosphorus restriction, appropriate targets of therapy, and strategies for safely prescribing phosphorus restriction in clinical practice. Given the markedly high phosphorus content of westernized diets, these studies should be a high priority in future research.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.